Ameritas Investment Partners’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.3K | Hold |
6,838
| – | – | ﹤0.01% | 2037 |
|
|
2025
Q1 | $37.1K | Hold |
6,838
| – | – | ﹤0.01% | 2272 |
|
|
2024
Q4 | $50.9K | Buy |
6,838
+1,940
| +40% | +$14.5K | ﹤0.01% | 2170 |
|
|
2024
Q3 | $39.1K | Hold |
4,898
| – | – | ﹤0.01% | 2335 |
|
|
2024
Q2 | $42.6K | Buy |
4,898
+1,179
| +32% | +$10.3K | ﹤0.01% | 2230 |
|
|
2024
Q1 | $76.9K | Buy |
3,719
+1,136
| +44% | +$23.5K | ﹤0.01% | 1899 |
|
|
2023
Q4 | $59.7K | Hold |
2,583
| – | – | ﹤0.01% | 2060 |
|
|
2023
Q3 | $20.6K | Buy |
2,583
+926
| +56% | +$7.4K | ﹤0.01% | 2522 |
|
|
2023
Q2 | $14.4K | Hold |
1,657
| – | – | ﹤0.01% | 2733 |
|
|
2023
Q1 | $4.87K | Hold |
1,657
| – | – | ﹤0.01% | 2864 |
|
|
2022
Q4 | $6.99K | Hold |
1,657
| – | – | ﹤0.01% | 2874 |
|
|
2022
Q3 | $13K | Hold |
1,657
| – | – | ﹤0.01% | 2705 |
|
|
2022
Q2 | $13K | Hold |
1,657
| – | – | ﹤0.01% | 2746 |
|
|
2022
Q1 | $20K | Hold |
1,657
| – | – | ﹤0.01% | 2557 |
|
|
2021
Q4 | $20K | Hold |
1,657
| – | – | ﹤0.01% | 2644 |
|
|
2021
Q3 | $17K | Hold |
1,657
| – | – | ﹤0.01% | 2771 |
|
|
2021
Q2 | $15K | Buy |
+1,657
| New | +$15K | ﹤0.01% | 2849 |
|
|
2020
Q2 | – | Sell |
-546
| Closed | -$6K | – | 3085 |
|
|
2020
Q1 | $6K | Hold |
546
| – | – | ﹤0.01% | 2745 |
|
|
2019
Q4 | $8K | Hold |
546
| – | – | ﹤0.01% | 2801 |
|
|
2019
Q3 | $10K | Hold |
546
| – | – | ﹤0.01% | 2745 |
|
|
2019
Q2 | $9K | Buy |
+546
| New | +$9K | ﹤0.01% | 2826 |
|